Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Detailed Action
This Office Action is in response to the Applicant’s reply received 8/5/26. Claims 1, 5, 7-9, 11, 12, 17, 20-23, 25-29, 31-32, 36, 40, 41, 44, 45, 51, 54-58, 60, and 66 are pending. Claims 8, 22, 23, 25-29, 31-32, 36, 40, 41, 44, 45, 51, 54-58, 60, and 66 are withdrawn. Claims 1, 5, 7-9, 11, 12, 17, 20, and 21 are considered on the merits.
Election/Restriction Requirement
Applicant’s election of Group I, claims 1-3 and 5-10, without traverse in the reply filed on 8/5/26 is acknowledged. Applicant elected the following species:
For leader peptide and B1 protein: leader peptide TfuA and B1 protein TfuB1 from Thermobifida fusca;
For affinity tag: histidine tag (His tag);
For structure of the conjugate protein: the first fusion protein has a second affinity tag having a selective affinity for a second affinity tag resin;
For Sortase: sortase A (SrtA); and
For sortase recognition motif: LPXTG (SEQ ID NO: 1);
As a result of these elections, claim 8 is withdrawn as the non-elected species from iii). In summary claims 8, 22, 23, 25-29, 31-32, 36, 40, 41, 44, 45, 51, 54-58, 60, and 66 are withdrawn as a result of this Election/Restriction requirement.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1, 5, 7-9, 11, 12, 17, 20, and 21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
The complete structure of this conjugated protein is indefinite for the following reasons:
The phrases “[component] is N-terminal and connected via a linker” is confusing because it does not clearly indicate how the components (protein of interest, sortase recognition motif, and binding pair member) are arranged. All proteins have an N-terminus. It is unclear what is connected to the N-terminal of each component of these fusion proteins. Applicant may wish to amend to “the protein of interest is connected via a linker to the N-terminus of the sortase recognition motif”. This provides a clear description of how the components are linked together. This also applies to other situations where “N-terminal and connected via a linker” appears in the claims including both (i) and (ii) of claim 1;
The final phrase “wherein the binding pair members comprise one or more leader peptides in tandem and one or more B1 proteins in tandem from a lasso peptide biosynthesis system that can form a heterodimer.” is unclear because “can form a heterodimer” leaves the final structure as optional and therefore undefined. Also ‘tandem’ is a relative term. In this case it is unclear what is ‘in tandem’ with the leader peptides or the one or more B1 proteins. Also it is unclear how the leader peptides are integrated into the lasso peptide biosynthesis to elucidate a final structure of the claims; And
The claim does not clearly identify how the 1st and 2nd fusion proteins are conjugated as limited in the preamble. It is presumed from the diagrams that both binding pair members link to for a heterodimer, but this structure is not clearly stated in the claims.
Closest Prior Art
Because of the significant 35 USC 112 issues above, it is difficult to clearly apply prior art to these claims. However, based on a comparison of the figures, it appears the closest prior art is WO2018/053180 (in IDS 3/9/26, also published as US 11236177). Current Fig. 1 and Fig 2 of WO’180 appear to disclose similar structures.
Request for Interview
The Examiner believes an interview would be useful in progressing this case to resolve the 35 USC 112 issues already listed. The Applicant is encouraged to contact Thane Underdahl at (303) 297-4299 to discuss the claims/claim amendments to place this case in condition for allowance prior to replying to this Office Action.
In response to this office action the applicant should specifically point out the support for any amendments made to the disclosure, including the claims (MPEP 714.02 and 2163.06).
CONTACT INFORMATION
Any inquiry concerning this communication or earlier communications from the examiner should be directed to THANE E UNDERDAHL whose telephone number is (303) 297-4299. The examiner can normally be reached Monday through Thursday, M-F 8-5 MST.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Fereydoun Sajjadi can be reached at (571) 272-3311.The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/THANE UNDERDAHL/Primary Examiner, Art Unit 1699